Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cystadenocarcinoma, Papillary

fluorodeoxyglucose f18 has been researched along with Cystadenocarcinoma, Papillary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, YF; Liu, RS; Ng, HT; Wang, PH; Yuan, CC1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Cystadenocarcinoma, Papillary

ArticleYear
Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report.
    Gynecologic oncology, 2000, Volume: 77, Issue:1

    Topics: Adult; CA-125 Antigen; Cystadenocarcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed

2000